Loading articles...
- Anxiety Disorders
Tired Yet Wired: Blame Your Stone-Age Brain for Modern Sleep Woes
Chronic stress keeps the ancient fight-or-flight response active, preventing restorative sleep despite physical exhaustion. This evolutionary mismatch drives modern insomnia.
- Depressive Disorder
Childhood Maltreatment Memories: Trustworthy, Not Fabricated
New research challenges the long-held notion that memories of childhood maltreatment are inherently unreliable, affirming their consistency and clinical utility.
- Depressive Disorder
Brief CBT Workshop Reduces Anxiety, Boosts Grit in Primary Students
A brief cognitive behavioral therapy workshop significantly reduced anxiety and improved active coping strategies and grit among primary school students in Malaysia.
- Depressive Disorder
Congressman Kean Jr. Reveals Depression Diagnosis After Absence
Representative Tom Kean Jr. disclosed a depression diagnosis following a four-month absence from Congress, highlighting the prevalence of mental health conditions.
- Depressive Disorder
New York's Old Boys' Clubs Offer Mental Health Buffer
Exclusive social clubs in New York City provide a structured environment that may mitigate mental health decline among members, fostering resilience through consistent social engagement and shared purpose.
- Post-Traumatic Stress Disorders
PTSD Not a Shield for Sexual Misconduct, Clinicians Affirm
Post-traumatic stress disorder does not mitigate accountability for sexual misconduct, a consensus among mental health professionals confirms, rejecting the notion of PTSD as a blanket excuse.
- Schizophrenia Spectrum and Other Psychotic Disorders
Adderall Execs Jailed; FDA Warns on Ketamine; Wellness Cult Psychosis
Executives received prison sentences for an Adderall distribution scheme. The FDA issued a warning regarding compounded ketamine. Wellness cults are linked to psychosis cases.
- Depressive Disorder
MDD Care Gaps Persist, Limiting Access to Effective Therapies
Major depressive disorder treatment faces significant access barriers, leaving many patients without adequate care despite available therapies.
- Substance Related Disorders
DEA Proposes Schedule I Classification for Synthetic 7-OH Products
The DEA proposes Schedule I classification for synthetic 7-hydroxymitragynine (7-OH) products, citing high abuse potential and lack of accepted medical use.
